<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Iran J Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">Iran J Med Sci</journal-id><journal-title-group><journal-title>Iranian Journal of Medical Sciences</journal-title></journal-title-group><issn pub-type="ppub">0253-0716</issn><issn pub-type="epub">1735-3688</issn><publisher><publisher-name>Iranian Journal of Medical Sciences</publisher-name><publisher-loc>Iran</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27840476</article-id><article-id pub-id-type="pmc">5103515</article-id><article-id pub-id-type="publisher-id">IJMS-41-10</article-id><article-categories><subj-group subj-group-type="heading"><subject>Oral</subject></subj-group></article-categories><title-group><article-title>Rhus Coriaria L. (Sumac) in Patients with Hyperlipidemia; A Double Blind Randomized Clinical Trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hajmohammadi</surname><given-names>Zahra</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Shams</surname><given-names>Mesbah</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Zibainejad</surname><given-names>Mohammad Javad</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Nimrouzi</surname><given-names>Majid</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Fardidi</surname><given-names>Pouya</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Heydari</surname><given-names>Mojtaba</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Departmen t of Internal Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran</aff><aff id="aff2"><label>2</label>Endocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran</aff><aff id="aff3"><label>3</label>Departmen t of Cardiology, Cardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran</aff><aff id="aff4"><label>4</label>Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran</aff><aff id="aff5"><label>5</label>Departm en t of Phytopharmaceuticals (Traditional Pharmacy), School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran</aff><pub-date pub-type="ppub"><month>5</month><year>2016</year></pub-date><volume>41</volume><issue>3 Suppl</issue><fpage>S10</fpage><lpage>S10</lpage><permissions><copyright-statement>Copyright: &#x000a9; Iranian Journal of Medical Sciences</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Background:</title><p>Lipid lowering effect of sumac is investigated in multiple animal studies with promising results. However, its clinical efficacy is not investigated adequately. This study is aimed to evaluate the lipid lowering effect of sumac in patients with Hyperlipidemia in a double blind randomized controlled trial.</p></sec><sec id="st2"><title>Methods:</title><p>Eighty patients with Hyperlipidemia according to NCEP-ATP III criteria were randomly allocated to receive the Rhus Coriaria L. (1000 mg/day) or placebo for two months. The patients were evaluated in terms of the serum triglyceride, total LDL, and HDL cholesterol. Systolic and diastolic blood pressures along with serum biochemistry profile including fasting blood sugar, liver and kidney function tests and complete blood count were evaluated before the enrolment of patients and after the intervention.</p></sec><sec id="st3"><title>Results:</title><p>No significant difference was observed between the sumac and placebo groups in term of mean reductions in total and LDL cholesterol and triglyceride levels. A significant increase in mean serum HDL cholesterol level was observed in the sumac group (41.18&#x000b1;8.2 vs. 44.65&#x000b1;8.4, P=0.001) after 2 months of intervention.</p></sec><sec id="st4"><title>Conclusion:</title><p>The study showed significant HDL cholesterol increasing effect of sumac supplementation in patients with Hyperlipidemia.</p></sec></abstract><kwd-group><kwd>Medicine</kwd><kwd>Traditional</kwd><kwd>Hyperlipidemias</kwd><kwd>Clinical trial</kwd></kwd-group></article-meta></front></article>